Global COVID Rapid Diagnostic Test Market Share

Statistics for the 2023 & 2024 Global COVID Rapid Diagnostic Test market share, created by Mordor Intelligence™ Industry Reports. Global COVID Rapid Diagnostic Test share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Consumables Research Laboratory Supplies Research Testing Kits Research COVID Rapid Diagnostic Test Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global COVID Rapid Diagnostic Test Industry

The COVID rapid diagnostic test market is moderately fragmented, with the presence of key players in the market. Some of the key companies in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, bioMérieux SA, Quest Diagnostics Incorporated, and Danaher Corporation, among others.

COVID Rapid Diagnostic Test Market Leaders

  1. Abbott Laboratories

  2. F. Hoffmann-La Roche Ltd

  3. Quest Diagnostics Incorporated

  4. Siemens Healthcare AG

  5. bioMerieux SA

*Disclaimer: Major Players sorted in no particular order

COVID Rapid Diagnostic Test Market Concentration

COVID Rapid Diagnostic Test Market Report Snapshots

COVID Rapid Diagnostic Test Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)